ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Natural Bladder Control, Go Less and Live More

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

The Onion: Cancer Fighter and Food Preserver

Probiotics improve cognition in Alzheimer's patients

Curcumin Reverses the Cellular Damage of Chronic Stress

 
Print Page
Email Article

Growing Knowledge About the Cholinergic System Shows the Evolution of Scientific Thinking

  [ 1 vote ]   [ Discuss This Article ]
By 1999 Progress Report by the NIA/NIH • www.ProHealth.com • December 13, 1999


In the mid-1970s, several teams of researchers discovered that levels of a neurotransmitter called acetylcholine fell sharply in people with AD. This discovery was important because acetylcholine is critically important in the process of forming memories and is used commonly by neurons in the hippocampus and cerebral cortex--regions devastated by AD. Those early findings were reproduced and expanded upon in many studies over the following years. These studies established the fact that acetylcholine levels fall somewhat in normal aging but drop by about 90 percent in people with Alzheimer's disease and that these steep declines are linked to memory impairment. This led to research on a broad front, including studies on the cells that use acetylcholine and the enzymes and other proteins that take part in its manufacture or activity--a framework known as the cholinergic system.

Much of this work was directed to searching for compounds that could increase the levels of acetylcholine, replace it, or slow its breakdown, all in the hopes of finding an effective treatment for AD. The two drugs that are currently approved for use in treating AD--donepezil and tacrine--act by inhibiting acetylcholinesterase, an enzyme that breaks down acetylcholine, and so maintain falling levels.

A recent study, conducted by scientists at the Mount Sinai Alzheimer's Disease Research Center in New York, has provided an opportunity for scientists to refine their thinking about the role of the cholinergic system in the early stages of AD (Davis et al., 1999). In this study, the researchers attempted to find out whether the loss of cholinergic function in specific areas of the brain occurs before, after, or at the same time as the earliest signs of cognitive deterioration. Their findings indicate that patients in early stages of the disease, while exhibiting memory deficits and classic AD signs of plaques and tangles, have relatively normal levels of the enzymes that regulate acetylcholine levels. Only in patients with severe AD did the researchers see greatly diminished levels of these enzymes. This suggests that overall deficits of these enzymes may not be an early sign of damage in the disease. However, the researchers were not able to measure acetylcholine levels directly, so it may be possible that overall acetylcholine levels are lower, or that there is a deficit elsewhere in the cholinergic system. It is also possible that more subtle losses may still occur early on in specific neuron populations.

Given these findings, it is possible that the positive effects of the current AD drugs in patients with mild to moderate AD are due to their ability to boost normal levels of this important chemical, rather than to an ability to maintain falling levels.

Source:
National Institutes of Health
National Institute on Aging
1999 PROGRESS REPORT ON ALZHEIMER'S DISEASE



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor® FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map